Nath Bio-Genes (India) Limited

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, COROMANDEL.BO has a market cap of 635.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while COROMANDEL.BO trades at ₹2,154.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas COROMANDEL.BO's P/E ratio is 26.53. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to COROMANDEL.BO's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to COROMANDEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check COROMANDEL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, COROMANDEL.NS has a market cap of 635.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while COROMANDEL.NS trades at ₹2,154.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas COROMANDEL.NS's P/E ratio is 26.14. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to COROMANDEL.NS's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to COROMANDEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check COROMANDEL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, FACT.NS has a market cap of 554.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while FACT.NS trades at ₹857.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas FACT.NS's P/E ratio is 1824.68. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to FACT.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to FACT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check FACT.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, FACT.BO has a market cap of 554.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while FACT.BO trades at ₹857.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas FACT.BO's P/E ratio is 1786.25. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to FACT.BO's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to FACT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check FACT.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, UPL.NS has a market cap of 544.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while UPL.NS trades at ₹644.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas UPL.NS's P/E ratio is 30.77. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to UPL.NS's ROE of +0.05%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to UPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check UPL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, PIIND.BO has a market cap of 447.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while PIIND.BO trades at ₹2,952.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas PIIND.BO's P/E ratio is 30.87. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to PIIND.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to PIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check PIIND.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, PIIND.NS has a market cap of 447.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while PIIND.NS trades at ₹2,952.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas PIIND.NS's P/E ratio is 30.82. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to PIIND.NS's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to PIIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check PIIND.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BAYERCROP.NS has a market cap of 216B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BAYERCROP.NS trades at ₹4,805.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BAYERCROP.NS's P/E ratio is 32.23. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BAYERCROP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to BAYERCROP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BAYERCROP.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SUMICHEM.NS has a market cap of 208.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SUMICHEM.NS trades at ₹418.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SUMICHEM.NS's P/E ratio is 39.23. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SUMICHEM.NS's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to SUMICHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SUMICHEM.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SUMICHEM.BO has a market cap of 208.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SUMICHEM.BO trades at ₹418.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SUMICHEM.BO's P/E ratio is 39.33. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SUMICHEM.BO's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to SUMICHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SUMICHEM.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, CHAMBLFERT.NS has a market cap of 183B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while CHAMBLFERT.NS trades at ₹456.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas CHAMBLFERT.NS's P/E ratio is 9.56. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to CHAMBLFERT.NS's ROE of +0.22%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to CHAMBLFERT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check CHAMBLFERT.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, CHAMBLFERT.BO has a market cap of 182.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while CHAMBLFERT.BO trades at ₹456.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas CHAMBLFERT.BO's P/E ratio is 9.82. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to CHAMBLFERT.BO's ROE of +0.22%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to CHAMBLFERT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check CHAMBLFERT.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, ATUL7.BO has a market cap of 179B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while ATUL7.BO trades at ₹7,100.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas ATUL7.BO's P/E ratio is N/A. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to ATUL7.BO's ROE of +0.10%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to ATUL7.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check ATUL7.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, EIDPARRY.BO has a market cap of 151.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while EIDPARRY.BO trades at ₹853.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas EIDPARRY.BO's P/E ratio is 13.19. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to EIDPARRY.BO's ROE of +0.11%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to EIDPARRY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check EIDPARRY.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, PARADEEP.NS has a market cap of 98.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while PARADEEP.NS trades at ₹121.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas PARADEEP.NS's P/E ratio is 11.95. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to PARADEEP.NS's ROE of +0.20%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to PARADEEP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check PARADEEP.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, PARADEEP.BO has a market cap of 98.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while PARADEEP.BO trades at ₹121.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas PARADEEP.BO's P/E ratio is 12.15. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to PARADEEP.BO's ROE of +0.20%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to PARADEEP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check PARADEEP.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SHARDACROP.NS has a market cap of 95.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SHARDACROP.NS trades at ₹1,057.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SHARDACROP.NS's P/E ratio is 16.87. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SHARDACROP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SHARDACROP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SHARDACROP.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SHARDACROP.BO has a market cap of 95.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SHARDACROP.BO trades at ₹1,057.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SHARDACROP.BO's P/E ratio is 17.11. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SHARDACROP.BO's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SHARDACROP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SHARDACROP.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, RCF.BO has a market cap of 70.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while RCF.BO trades at ₹128.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas RCF.BO's P/E ratio is 22.61. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to RCF.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to RCF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check RCF.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, RCF.NS has a market cap of 70.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while RCF.NS trades at ₹128.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas RCF.NS's P/E ratio is 22.61. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to RCF.NS's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to RCF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check RCF.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, GSFC.NS has a market cap of 65.3B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while GSFC.NS trades at ₹163.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas GSFC.NS's P/E ratio is 9.42. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to GSFC.NS's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to GSFC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check GSFC.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, GSFC.BO has a market cap of 65.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while GSFC.BO trades at ₹163.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas GSFC.BO's P/E ratio is 9.77. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to GSFC.BO's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to GSFC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check GSFC.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, PICCADIL.BO has a market cap of 56.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while PICCADIL.BO trades at ₹570.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas PICCADIL.BO's P/E ratio is 41.33. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to PICCADIL.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to PICCADIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check PICCADIL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, RALLIS.BO has a market cap of 50.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while RALLIS.BO trades at ₹258.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas RALLIS.BO's P/E ratio is 30.10. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to RALLIS.BO's ROE of +0.09%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to RALLIS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check RALLIS.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, RALLIS.NS has a market cap of 50.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while RALLIS.NS trades at ₹258.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas RALLIS.NS's P/E ratio is 29.44. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to RALLIS.NS's ROE of +0.09%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to RALLIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check RALLIS.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KSCL.BO has a market cap of 47.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KSCL.BO trades at ₹925.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KSCL.BO's P/E ratio is 15.69. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KSCL.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to KSCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check KSCL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, DHANUKA.BO has a market cap of 46.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while DHANUKA.BO trades at ₹1,025.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas DHANUKA.BO's P/E ratio is 6.56. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to DHANUKA.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to DHANUKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check DHANUKA.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, DHANUKA.NS has a market cap of 46.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while DHANUKA.NS trades at ₹1,025.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas DHANUKA.NS's P/E ratio is 6.55. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to DHANUKA.NS's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to DHANUKA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check DHANUKA.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MBAPL.NS has a market cap of 45.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MBAPL.NS trades at ₹523.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MBAPL.NS's P/E ratio is 43.76. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MBAPL.NS's ROE of +0.26%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MBAPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MBAPL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NFL.BO has a market cap of 37.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NFL.BO trades at ₹75.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NFL.BO's P/E ratio is 19.03. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NFL.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to NFL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NFL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NFL.NS has a market cap of 37B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NFL.NS trades at ₹75.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NFL.NS's P/E ratio is 19.01. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NFL.NS's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to NFL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NFL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MANGCHEFER.NS has a market cap of 36.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MANGCHEFER.NS trades at ₹308.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MANGCHEFER.NS's P/E ratio is 22.67. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MANGCHEFER.NS's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MANGCHEFER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MANGCHEFER.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MANGCHEFER.BO has a market cap of 36.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MANGCHEFER.BO trades at ₹308.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MANGCHEFER.BO's P/E ratio is 22.63. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MANGCHEFER.BO's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MANGCHEFER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MANGCHEFER.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KRISHANA.NS has a market cap of 35.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KRISHANA.NS trades at ₹572.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KRISHANA.NS's P/E ratio is 27.22. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KRISHANA.NS's ROE of +0.34%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to KRISHANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check KRISHANA.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BNHOLDINGS.BO has a market cap of 34.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BNHOLDINGS.BO trades at ₹355.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BNHOLDINGS.BO's P/E ratio is 26.71. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BNHOLDINGS.BO's ROE of +0.16%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BNHOLDINGS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BNHOLDINGS.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NACLIND.BO has a market cap of 32.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NACLIND.BO trades at ₹166.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NACLIND.BO's P/E ratio is -81.54. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NACLIND.BO's ROE of -0.10%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NACLIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NACLIND.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NACLIND.NS has a market cap of 32.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NACLIND.NS trades at ₹166.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NACLIND.NS's P/E ratio is -81.50. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NACLIND.NS's ROE of -0.10%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NACLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NACLIND.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BHAGCHEM.BO has a market cap of 29B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BHAGCHEM.BO trades at ₹223.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BHAGCHEM.BO's P/E ratio is 230.88. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BHAGCHEM.BO's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BHAGCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BHAGCHEM.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BHAGCHEM.NS has a market cap of 28.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BHAGCHEM.NS trades at ₹222.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BHAGCHEM.NS's P/E ratio is 229.24. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BHAGCHEM.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BHAGCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BHAGCHEM.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, CIANAGRO.BO has a market cap of 24.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while CIANAGRO.BO trades at ₹864.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas CIANAGRO.BO's P/E ratio is 21.55. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to CIANAGRO.BO's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to CIANAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check CIANAGRO.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, VENKYS.BO has a market cap of 24.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while VENKYS.BO trades at ₹1,714.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas VENKYS.BO's P/E ratio is -57.49. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to VENKYS.BO's ROE of +0.04%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to VENKYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check VENKYS.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KSE.NS has a market cap of 22.3B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KSE.NS trades at ₹697.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KSE.NS's P/E ratio is N/A. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KSE.NS's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to KSE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check KSE.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, INSECTICID.NS has a market cap of 18.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while INSECTICID.NS trades at ₹645.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas INSECTICID.NS's P/E ratio is 13.23. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to INSECTICID.NS's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to INSECTICID.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check INSECTICID.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, INSECTICID.BO has a market cap of 18.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while INSECTICID.BO trades at ₹644.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas INSECTICID.BO's P/E ratio is 13.21. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to INSECTICID.BO's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to INSECTICID.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check INSECTICID.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, IPL.BO has a market cap of 17.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while IPL.BO trades at ₹148.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas IPL.BO's P/E ratio is 15.58. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to IPL.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to IPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check IPL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, IPL.NS has a market cap of 17B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while IPL.NS trades at ₹147.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas IPL.NS's P/E ratio is 15.56. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to IPL.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to IPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check IPL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, ASTEC.BO has a market cap of 14.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while ASTEC.BO trades at ₹659.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas ASTEC.BO's P/E ratio is -15.59. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to ASTEC.BO's ROE of -0.30%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to ASTEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check ASTEC.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, ASTEC.NS has a market cap of 14.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while ASTEC.NS trades at ₹658.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas ASTEC.NS's P/E ratio is -15.58. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to ASTEC.NS's ROE of -0.30%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to ASTEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check ASTEC.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SPIC.BO has a market cap of 13.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SPIC.BO trades at ₹67.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SPIC.BO's P/E ratio is 7.39. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SPIC.BO's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SPIC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SPIC.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SPIC.NS has a market cap of 13.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SPIC.NS trades at ₹67.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SPIC.NS's P/E ratio is 6.80. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SPIC.NS's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SPIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SPIC.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BHARATRAS.BO has a market cap of 13.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BHARATRAS.BO trades at ₹1,573.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BHARATRAS.BO's P/E ratio is 19.61. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BHARATRAS.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BHARATRAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BHARATRAS.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BHARATRAS.NS has a market cap of 13B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BHARATRAS.NS trades at ₹1,570.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BHARATRAS.NS's P/E ratio is 19.23. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BHARATRAS.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BHARATRAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BHARATRAS.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MOL.BO has a market cap of 12.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MOL.BO trades at ₹49.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MOL.BO's P/E ratio is 31.25. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MOL.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MOL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MOL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MOL.NS has a market cap of 12.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MOL.NS trades at ₹49.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MOL.NS's P/E ratio is 31.22. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MOL.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MOL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MOL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MADRASFERT.NS has a market cap of 10.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MADRASFERT.NS trades at ₹66.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MADRASFERT.NS's P/E ratio is 148.36. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MADRASFERT.NS's ROE of -0.53%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to MADRASFERT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MADRASFERT.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MADRASFERT.BO has a market cap of 10.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MADRASFERT.BO trades at ₹66.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MADRASFERT.BO's P/E ratio is 148.27. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MADRASFERT.BO's ROE of -0.53%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MADRASFERT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MADRASFERT.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BSHSL.NS has a market cap of 10.3B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BSHSL.NS trades at ₹98.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BSHSL.NS's P/E ratio is 36.75. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BSHSL.NS's ROE of +0.25%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BSHSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BSHSL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BAJAJST.BO has a market cap of 9.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BAJAJST.BO trades at ₹474.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BAJAJST.BO's P/E ratio is 18.93. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BAJAJST.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BAJAJST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BAJAJST.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, ZUARI.NS has a market cap of 9.3B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while ZUARI.NS trades at ₹220.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas ZUARI.NS's P/E ratio is 0.96. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to ZUARI.NS's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to ZUARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check ZUARI.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BLUECLOUDS.BO has a market cap of 9.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BLUECLOUDS.BO trades at ₹19.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BLUECLOUDS.BO's P/E ratio is 14.87. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BLUECLOUDS.BO's ROE of +0.49%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BLUECLOUDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BLUECLOUDS.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, DHARMAJ.NS has a market cap of 9.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while DHARMAJ.NS trades at ₹270.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas DHARMAJ.NS's P/E ratio is 18.93. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to DHARMAJ.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to DHARMAJ.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check DHARMAJ.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, DHARMAJ.BO has a market cap of 9.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while DHARMAJ.BO trades at ₹270.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas DHARMAJ.BO's P/E ratio is 18.95. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to DHARMAJ.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to DHARMAJ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check DHARMAJ.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, HERANBA.BO has a market cap of 7.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while HERANBA.BO trades at ₹192.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas HERANBA.BO's P/E ratio is -12.94. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to HERANBA.BO's ROE of -0.07%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to HERANBA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check HERANBA.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, HERANBA.NS has a market cap of 7.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while HERANBA.NS trades at ₹190.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas HERANBA.NS's P/E ratio is -12.72. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to HERANBA.NS's ROE of -0.07%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to HERANBA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check HERANBA.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KSE.BO has a market cap of 6.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KSE.BO trades at ₹205.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KSE.BO's P/E ratio is 5.37. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KSE.BO's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to KSE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check KSE.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BESTAGRO.BO has a market cap of 6.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BESTAGRO.BO trades at ₹17.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BESTAGRO.BO's P/E ratio is 9.20. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BESTAGRO.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BESTAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BESTAGRO.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BESTAGRO.NS has a market cap of 6.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BESTAGRO.NS trades at ₹17.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BESTAGRO.NS's P/E ratio is 8.72. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BESTAGRO.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BESTAGRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BESTAGRO.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SHINDL.BO has a market cap of 5.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SHINDL.BO trades at ₹148.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SHINDL.BO's P/E ratio is 46.99. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SHINDL.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SHINDL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SHINDL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SVRL.BO has a market cap of 5.7B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SVRL.BO trades at ₹259.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SVRL.BO's P/E ratio is 22.77. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SVRL.BO's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SVRL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SVRL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KNAGRI.NS has a market cap of 5.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KNAGRI.NS trades at ₹225.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KNAGRI.NS's P/E ratio is 15.32. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KNAGRI.NS's ROE of N/A. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to KNAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check KNAGRI.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KHAICHEM.BO has a market cap of 5.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KHAICHEM.BO trades at ₹54.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KHAICHEM.BO's P/E ratio is 7.68. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KHAICHEM.BO's ROE of +0.31%. Regarding short-term risk, NATHBIOGEN.BO and KHAICHEM.BO have similar daily volatility (2.25).Check KHAICHEM.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KHAICHEM.NS has a market cap of 5.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KHAICHEM.NS trades at ₹53.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KHAICHEM.NS's P/E ratio is 7.26. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KHAICHEM.NS's ROE of +0.31%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to KHAICHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check KHAICHEM.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MODINATUR.BO has a market cap of 5B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MODINATUR.BO trades at ₹378.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MODINATUR.BO's P/E ratio is 12.98. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MODINATUR.BO's ROE of +0.32%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MODINATUR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MODINATUR.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, ARIES.NS has a market cap of 4.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while ARIES.NS trades at ₹379.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas ARIES.NS's P/E ratio is 11.35. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to ARIES.NS's ROE of +0.15%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to ARIES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check ARIES.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MISHTANN.BO has a market cap of 4.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MISHTANN.BO trades at ₹4.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MISHTANN.BO's P/E ratio is 1.45. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MISHTANN.BO's ROE of +0.35%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to MISHTANN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MISHTANN.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, RAMAPHO.BO has a market cap of 4.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while RAMAPHO.BO trades at ₹135.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas RAMAPHO.BO's P/E ratio is 9.15. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to RAMAPHO.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to RAMAPHO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check RAMAPHO.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, RAMAPHO.NS has a market cap of 4.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while RAMAPHO.NS trades at ₹135.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas RAMAPHO.NS's P/E ratio is 8.96. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to RAMAPHO.NS's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to RAMAPHO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check RAMAPHO.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SHIVALIK.NS has a market cap of 4.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SHIVALIK.NS trades at ₹264.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SHIVALIK.NS's P/E ratio is 32.63. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SHIVALIK.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to SHIVALIK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SHIVALIK.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, IGCL.NS has a market cap of 3.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while IGCL.NS trades at ₹60.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas IGCL.NS's P/E ratio is 11.09. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to IGCL.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to IGCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check IGCL.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, GOODRICKE.BO has a market cap of 3.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while GOODRICKE.BO trades at ₹165.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas GOODRICKE.BO's P/E ratio is 19.59. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to GOODRICKE.BO's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to GOODRICKE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check GOODRICKE.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, KINGSINFR.BO has a market cap of 3.2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while KINGSINFR.BO trades at ₹131.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas KINGSINFR.BO's P/E ratio is 23.66. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to KINGSINFR.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to KINGSINFR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check KINGSINFR.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NATHBIOGEN.NS has a market cap of 2.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NATHBIOGEN.NS trades at ₹152.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NATHBIOGEN.NS's P/E ratio is 6.74. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NATHBIOGEN.NS's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NATHBIOGEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NATHBIOGEN.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NOVAAGRI.NS has a market cap of 2.6B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NOVAAGRI.NS trades at ₹29.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NOVAAGRI.NS's P/E ratio is 15.87. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NOVAAGRI.NS's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NOVAAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NOVAAGRI.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NAGAFERT.BO has a market cap of 2.5B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NAGAFERT.BO trades at ₹4.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NAGAFERT.BO's P/E ratio is -8.91. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NAGAFERT.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NAGAFERT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NAGAFERT.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NAGAFERT.NS has a market cap of 2.5B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NAGAFERT.NS trades at ₹4.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NAGAFERT.NS's P/E ratio is -8.83. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NAGAFERT.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NAGAFERT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NAGAFERT.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, INDOUS.BO has a market cap of 2.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while INDOUS.BO trades at ₹107.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas INDOUS.BO's P/E ratio is 14.48. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to INDOUS.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to INDOUS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check INDOUS.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, INDOUS.NS has a market cap of 2.1B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while INDOUS.NS trades at ₹106.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas INDOUS.NS's P/E ratio is 14.40. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to INDOUS.NS's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to INDOUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check INDOUS.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, RBS.NS has a market cap of 2B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while RBS.NS trades at ₹88.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas RBS.NS's P/E ratio is 12.89. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to RBS.NS's ROE of N/A. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to RBS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check RBS.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, VIJSOLX.BO has a market cap of 1.9B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while VIJSOLX.BO trades at ₹598.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas VIJSOLX.BO's P/E ratio is 12.51. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to VIJSOLX.BO's ROE of +0.04%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to VIJSOLX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check VIJSOLX.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, HOACFOODS.NS has a market cap of 1.8B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while HOACFOODS.NS trades at ₹416.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas HOACFOODS.NS's P/E ratio is 61.51. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to HOACFOODS.NS's ROE of N/A. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to HOACFOODS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check HOACFOODS.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, EQUIPPP.BO has a market cap of 1.5B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while EQUIPPP.BO trades at ₹14.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas EQUIPPP.BO's P/E ratio is 213.57. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to EQUIPPP.BO's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to EQUIPPP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check EQUIPPP.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, EQUIPPP.NS has a market cap of 1.5B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while EQUIPPP.NS trades at ₹14.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas EQUIPPP.NS's P/E ratio is 213.14. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to EQUIPPP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to EQUIPPP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check EQUIPPP.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, MSL.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while MSL.BO trades at ₹128.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas MSL.BO's P/E ratio is 13.58. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to MSL.BO's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.BO is more volatile compared to MSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check MSL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SBECSUG.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SBECSUG.BO trades at ₹29.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SBECSUG.BO's P/E ratio is -5.51. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SBECSUG.BO's ROE of +0.33%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SBECSUG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SBECSUG.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, SSLEL.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while SSLEL.BO trades at ₹267.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas SSLEL.BO's P/E ratio is -5.92. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to SSLEL.BO's ROE of +0.11%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to SSLEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check SSLEL.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NARMADA.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NARMADA.BO trades at ₹36.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NARMADA.BO's P/E ratio is 31.64. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NARMADA.BO's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NARMADA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NARMADA.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, NARMADA.NS has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while NARMADA.NS trades at ₹35.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas NARMADA.NS's P/E ratio is 31.28. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to NARMADA.NS's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to NARMADA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check NARMADA.NS's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, BHARATAGRI.BO has a market cap of 1.3B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while BHARATAGRI.BO trades at ₹25.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas BHARATAGRI.BO's P/E ratio is -64.95. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to BHARATAGRI.BO's ROE of -0.04%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to BHARATAGRI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check BHARATAGRI.BO's competition here

NATHBIOGEN.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.BO stands at 2.9B. In comparison, INDSUCR.BO has a market cap of 1.3B. Regarding current trading prices, NATHBIOGEN.BO is priced at ₹152.60, while INDSUCR.BO trades at ₹74.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.BO currently has a P/E ratio of 6.73, whereas INDSUCR.BO's P/E ratio is 3.16. In terms of profitability, NATHBIOGEN.BO's ROE is +0.07%, compared to INDSUCR.BO's ROE of +0.16%. Regarding short-term risk, NATHBIOGEN.BO is less volatile compared to INDSUCR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.BO.Check INDSUCR.BO's competition here